---
$id: https://graph.org.ai/products/commodity/51171633
$type: Product
source: UNSPSC
code: "51171633"
title: "Lubiprostone"
class: "51171600"
classTitle: "Laxatives"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lubiprostone

**UNSPSC Code**: 51171633
**Class**: [Laxatives](Laxatives.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a prostaglandin analogue with the molecular formula C20H32F2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7662KG2R6K, chemically known as prostan-1-oic acid, 16,16-difluoro-11-hydroxy-9,15-dioxo-, (11alpha)- but generally known as lubiprostone, which bears US NIH Compound Identifier 157920. European Medicines Agency schedules Lubiprostone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32077. The term LUBIPROSTONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, No. 2, 2003, List 49). World Health Organization schedules lubiprostone in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule lubiprostone under HS 29375000 and SITC 54156. As of Q4 2014, LUBIPROSTONE remains the US FDA Preferred Term for this commodity. Lubiprostone bears US NLM identifiers UMLS ID C1684405 and NCI Concept Code C66040. SMILES: FC(F)(C1(OC2C(C(C(=O)C2)CCCCCCC(=O)O)CC1)O)CCCC.

